AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6295133 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention to surgical and histologic details during initial procedures
Number of subjects: 18
Study 30942510 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of saffron (two pills per day) for 3 months
Number of subjects: 64
Study 30942510 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules (two pills per day) for 3 months
Number of subjects: 64
Study 28287797 — intervention group
Group type: EXPERIMENTAL
Intervention: RELATE with CoupleCARE (RCC)
Number of subjects: 182
Study 28287797 — intervention group
Group type: EXPERIMENTAL
Intervention: RELATE online assessment with feedback and relationship goal setting (RELATE)
Number of subjects: 182
Study 28287797 — intervention group
Group type: COMPARATOR
Intervention: Book reading control condition (control)
Number of subjects: 182
Study 28287797 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship education (RE)
Number of subjects: 182
Study 27412550 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing combined with peer participation
Number of subjects: 100
Study 27412550 — intervention group
Group type: COMPARATOR
Intervention: Traditional management
Number of subjects: 100
Study 25222894 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal decolonization
Number of subjects: 1000
Study 25222894 — intervention group
Group type: COMPARATOR
Intervention: Screening and isolation
Number of subjects: 1000
Study 25222894 — intervention group
Group type: COMPARATOR
Intervention: Targeted decolonization
Number of subjects: 1000
Study 22624776 — intervention group
Group type: EXPERIMENTAL
Intervention: KT intervention (three interactive educational sessions, action planning, audit and feedback reports, internal champions, reminders/point-of-care tools)
Number of subjects: 40
Study 22624776 — intervention group
Group type: EXPERIMENTAL
Intervention: KT intervention
Number of subjects: 40
Study 22624776 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention, received educational materials as part of the Ontario Osteoporosis Strategy)
Number of subjects: 40
Study 20226444 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin plus leuprolide acetate (LA) placebo
Number of subjects: 35
Study 20226444 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (LA)
Number of subjects: 35
Study 20226444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 17565560 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Intervention (MI)
Number of subjects: 198
Study 17565560 — intervention group
Group type: COMPARATOR
Intervention: Feedback Only (FO)
Number of subjects: 198
Study 16236177 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline (100 mg initial dose, then 50 mg every 12 hours for 5 to 14 days)
Number of subjects: 825
Study 16236177 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin (500/500 mg every 6 hours or adjusted for renal dysfunction for 5 to 14 days)
Number of subjects: 825
Study 16236177 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 825
Study 16236177 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 825
Study 11940029 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum neurotoxin Type A (BoNTA) intramuscular injections to triceps surae (800 U Dysport) and functional electrical stimulation (FES) of the common peroneal nerve with physiotherapy
Number of subjects: 21
Study 11940029 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy only (Control)
Number of subjects: 21
Study 9535593 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (40 min of bench stepping; 15 steps x min[‐1])
Number of subjects: 10
Study 9535593 — intervention group
Group type: COMPARATOR
Intervention: Control (no prior exercise)
Number of subjects: 10
Study 8588792 — intervention group
Group type: EXPERIMENTAL
Intervention: dimenhydrinate (100 mg)
Number of subjects: 20
Study 8588792 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 2228399 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg dl-fenfluramine/meal
Number of subjects: 16
Study 2228399 — intervention group
Group type: COMPARATOR
Intervention: placebo/meal
Number of subjects: 16
Study 2228399 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg dl-fenfluramine/no meal
Number of subjects: 16
Study 2228399 — intervention group
Group type: COMPARATOR
Intervention: placebo/no meal
Number of subjects: 16
Study 338088 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Makari skin test
Number of subjects: 118
Study 31324663 — intervention group
Group type: EXPERIMENTAL
Intervention: Eligible patients for clinical trials
Number of subjects: 577
Study 31324663 — intervention group
Group type: EXPERIMENTAL
Intervention: Invited patients
Number of subjects: 577
Study 31324663 — intervention group
Group type: EXPERIMENTAL
Intervention: Included patients
Number of subjects: 577
Study 31324663 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvitation associated with older age
Number of subjects: 577
Study 31324663 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall eligibility and participation rates
Number of subjects: 577
Study 27603578 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein hydrolysate (WPH)
Number of subjects: 20
Study 27603578 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (CHO)
Number of subjects: 20
Study 27603578 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthening contractions
Number of subjects: 20
Study 27603578 — intervention group
Group type: COMPARATOR
Intervention: Shortening contractions
Number of subjects: 20
Study 25707693 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-antigen Staphylococcus aureus vaccine (SA3Ag)
Number of subjects: 408
Study 23949071 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Passive Movement (RPM) exercise
Number of subjects: 45
Study 23949071 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated Active Movement (RAM) exercise
Number of subjects: 45
Study 23949071 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 45
Study 22533801 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 weeks of reading and language intervention
Number of subjects: 57
Study 22533801 — intervention group
Group type: COMPARATOR
Intervention: Waiting control (20 weeks of intervention after a delay)
Number of subjects: 57
Study 19436218 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV risk reduction intervention
Number of subjects: 48585
Study 17451692 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH stimulation test
Number of subjects: 20
Study 17451692 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonobese PCOS patients without insulin resistance)
Number of subjects: 20
Study 15075548 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E HIV vaccine trial participation
Number of subjects: 2545
Study 11158948 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute ascorbic acid treatment (2 g po)
Number of subjects: 39
Study 11158948 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic ascorbic acid treatment (500 mg/day for 1 month)
Number of subjects: 39
Study 11158948 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 39
Study 9563860 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure tourniquet system
Number of subjects: 26
Study 9563860 — intervention group
Group type: COMPARATOR
Intervention: High-pressure tourniquet system
Number of subjects: 26
Study 7951197 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate sleep group
Number of subjects: 0
Study 7951197 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal sleep group
Number of subjects: 0
Study 7951197 — intervention group
Group type: COMPARATOR
Intervention: Normal waking group
Number of subjects: 0
Study 7951197 — intervention group
Group type: COMPARATOR
Intervention: Sleep deprivation group
Number of subjects: 0
Study 3606869 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic appearance of microcalcifications
Number of subjects: 92
Study 29512838 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilisation splint treatment
Number of subjects: 80
Study 29512838 — intervention group
Group type: COMPARATOR
Intervention: Counselling and masticatory muscle exercises (Control)
Number of subjects: 80
Study 27590017 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg PPS
Number of subjects: 4
Study 27590017 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg PPS
Number of subjects: 4
Study 23804582 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle change with metformin
Number of subjects: 706
Study 23804582 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle change with placebo
Number of subjects: 706
Study 23804582 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle change without metformin
Number of subjects: 706
Study 22320846 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle rehabilitation
Number of subjects: 40
Study 22320846 — intervention group
Group type: COMPARATOR
Intervention: Dapoxetine 30 mg
Number of subjects: 40
Study 22320846 — intervention group
Group type: COMPARATOR
Intervention: Dapoxetine 60 mg
Number of subjects: 40
Study 20827195 — intervention group
Group type: EXPERIMENTAL
Intervention: High cut-off haemodialysis
Number of subjects: 0
Study 20827195 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib-based chemotherapy
Number of subjects: 0
Study 20827195 — intervention group
Group type: COMPARATOR
Intervention: Plasma exchange
Number of subjects: 0
Study 20827195 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel chemotherapy agents
Number of subjects: 0
Study 18983759 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 0.6 g + folic acid 500 microg/day
Number of subjects: 166
Study 18983759 — intervention group
Group type: COMPARATOR
Intervention: Folic acid 500 microg/day alone
Number of subjects: 166
Study 16025785 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive acupuncture treatment (10 sessions over 3-4 weeks)
Number of subjects: 24
Study 16025785 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture treatment (control group)
Number of subjects: 24
Study 11817926 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-week dietary/physical activity intervention
Number of subjects: 0
Study 11817926 — intervention group
Group type: COMPARATOR
Intervention: General health intervention
Number of subjects: 0
Study 10027375 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior fundoplication
Number of subjects: 107
Study 10027375 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 107
Study 8964646 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-apheresis
Number of subjects: 47
Study 8964646 — intervention group
Group type: COMPARATOR
Intervention: Diet and lipid-lowering drugs
Number of subjects: 47
Study 2178128 — intervention group
Group type: EXPERIMENTAL
Intervention: Ditiocarb
Number of subjects: 389
Study 2178128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 6113797 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 83
Study 6113797 — intervention group
Group type: COMPARATOR
Intervention: Meprobamate (250 mg)
Number of subjects: 83
Study 6113797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 31808635 — intervention group
Group type: EXPERIMENTAL
Intervention: Canephron N
Number of subjects: 51
Study 31808635 — intervention group
Group type: COMPARATOR
Intervention: Cystone
Number of subjects: 51
Study 28906595 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipital donor sites
Number of subjects: 108
Study 28906595 — intervention group
Group type: COMPARATOR
Intervention: Thigh donor sites
Number of subjects: 108
Study 25918759 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho/EMD/FDBA (OEF)
Number of subjects: 74
Study 25918759 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho/EMD/DFDBA (OED)
Number of subjects: 74
Study 25918759 — intervention group
Group type: COMPARATOR
Intervention: Ortho/EMD alone (OE)
Number of subjects: 74
Study 23769121 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) therapy
Number of subjects: 0
Study 23769121 — intervention group
Group type: COMPARATOR
Intervention: Control plus HBO therapy
Number of subjects: 0
Study 23769121 — intervention group
Group type: EXPERIMENTAL
Intervention: I/R plus HBO therapy
Number of subjects: 0
Study 23769121 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 23769121 — intervention group
Group type: COMPARATOR
Intervention: I/R group
Number of subjects: 0
Study 21067882 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection without radiotherapy
Number of subjects: 80
Study 21067882 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection with external beam radiotherapy (RadRx)
Number of subjects: 80
Study 21067882 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal irradiation and re‐implantation (ECRRI) without radiotherapy
Number of subjects: 80
Study 21067882 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal irradiation and re‐implantation (ECRRI) with radiotherapy (RadRx)
Number of subjects: 80
Study 21067882 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 19403877 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg rhTSH
Number of subjects: 90
Study 19403877 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg rhTSH/24-h interval
Number of subjects: 90
Study 19403877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 15476903 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSorb diclofenac K 25 mg
Number of subjects: 265
Study 15476903 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSorb diclofenac K 50 mg
Number of subjects: 265
Study 15476903 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSorb diclofenac K 100 mg
Number of subjects: 265
Study 15476903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study 11681767 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (7 mg/24 hours)
Number of subjects: 70
Study 11681767 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 70
Study 9603132 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical soft tissue lubricant
Number of subjects: 10
Study 9603132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7996958 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic stenting
Number of subjects: 201
Study 7996958 — intervention group
Group type: COMPARATOR
Intervention: Surgical biliary bypass
Number of subjects: 201
Study 2841839 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate, high-fiber diet
Number of subjects: 6
Study 2841839 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate, low-fiber diet
Number of subjects: 6
Study 29458316 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-dense formulation (1.5 kcal/mL)
Number of subjects: 4000
Study 29458316 — intervention group
Group type: COMPARATOR
Intervention: Routine enteral feed formulation (1 kcal/mL)
Number of subjects: 4000
Study 26580691 — intervention group
Group type: EXPERIMENTAL
Intervention: MAX intervention group (n = 20)
Number of subjects: 41
Study 26580691 — intervention group
Group type: COMPARATOR
Intervention: Health Education group (n = 21)
Number of subjects: 41
Study 24655814 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change counselling intervention (glaucoma education and motivational support package)
Number of subjects: 208
Study 24655814 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care (control group)
Number of subjects: 208
Study 24655814 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change counselling intervention
Number of subjects: 208
Study 22718559 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational film about prenatal examinations
Number of subjects: 390
Study 22718559 — intervention group
Group type: COMPARATOR
Intervention: Control group (no informational film)
Number of subjects: 390
Study 22718559 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational film
Number of subjects: 390
Study 20047573 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypersomnia patients
Number of subjects: 2208
Study 20047573 — intervention group
Group type: COMPARATOR
Intervention: Controls (age and gender adjusted citizens)
Number of subjects: 2208
Study 19211941 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure training (3 sets to voluntary exhaustion)
Number of subjects: 0
Study 19211941 — intervention group
Group type: COMPARATOR
Intervention: Nonfailure training (4 sets with submaximal repetitions)
Number of subjects: 0
Study 19211941 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Failure and Nonfailure)
Number of subjects: 0
Study 15142025 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy dynamic preload (1 set of 5 repetition maximum back squats)
Number of subjects: 19
Study 15142025 — intervention group
Group type: EXPERIMENTAL
Intervention: 5RM back squat
Number of subjects: 19
Study 15142025 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic preload exercise protocol
Number of subjects: 19
Study 15142025 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated exposure to heavy dynamic preload exercise protocol
Number of subjects: 19
Study 11486642 — intervention group
Group type: EXPERIMENTAL
Intervention: Egoism priming
Number of subjects: 0
Study 11486642 — intervention group
Group type: COMPARATOR
Intervention: Altruism priming
Number of subjects: 0
Study 11486642 — intervention group
Group type: COMPARATOR
Intervention: Neutral priming
Number of subjects: 0
Study 9595924 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg by mouth from day 5 to day 24 of the menstrual cycle
Number of subjects: 88
Study 9595924 — intervention group
Group type: COMPARATOR
Intervention: Placebo 10 mg by mouth from day 5 to day 24 of the menstrual cycle
Number of subjects: 88
Study 8071049 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopromide (300 mg I/kg)
Number of subjects: 200
Study 8071049 — intervention group
Group type: COMPARATOR
Intervention: Ioversol (300 mg I/kg)
Number of subjects: 200
Study 8071049 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol (300 mg I/kg)
Number of subjects: 200
Study 8071049 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopromide, Ioversol, Iopamidol
Number of subjects: 200
Study 2895662 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (bendrofluazide or propranolol)
Number of subjects: 17354
Study 2895662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17354
Study 2895662 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 17354
Study 2895662 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 17354
Study 2895662 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in smokers)
Number of subjects: 17354
Study 29253463 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 937
Study 29253463 — intervention group
Group type: EXPERIMENTAL
Intervention: SAVR
Number of subjects: 937
Study 28084056 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 40
Study 28084056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 26602538 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile feedback
Number of subjects: 10
Study 26602538 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint torque feedback
Number of subjects: 10
Study 26602538 — intervention group
Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 10
Study 24392599 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily insulin lispro mix 75/25 (LM75/25)
Number of subjects: 2000
Study 24392599 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily insulin glargine (GL)
Number of subjects: 2000
Study 22005624 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA) measured by accelerometry
Number of subjects: 337
Study 22005624 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary time measured by accelerometry
Number of subjects: 337
Study 18689149 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 diabetes patients with good glycemic control (HbA1c ≤ 8%)
Number of subjects: 30
Study 18689149 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 diabetes patients with poor glycemic control (HbA1c > 8%)
Number of subjects: 30
Study 18689149 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 30
Study 16879519 — intervention group
Group type: COMPARATOR
Intervention: N2O/O2-fentanyl
Number of subjects: 24
Study 16879519 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O/O2-sevoflurane
Number of subjects: 24
Study 14976918 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-fluorescence
Number of subjects: 102
Study 14976918 — intervention group
Group type: COMPARATOR
Intervention: White light
Number of subjects: 102
Study 10696631 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured lipid emulsion
Number of subjects: 22
Study 10696631 — intervention group
Group type: COMPARATOR
Intervention: Long-chain triacylglycerol emulsion
Number of subjects: 22
Study 9175175 — intervention group
Group type: COMPARATOR
Intervention: Powdered ginger 4 g daily for 3 months
Number of subjects: 0
Study 9175175 — intervention group
Group type: COMPARATOR
Intervention: Single dose of powdered ginger 10 g
Number of subjects: 0
Study 9175175 — intervention group
Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to healthy individuals
Number of subjects: 0
Study 9175175 — intervention group
Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to CAD patients with NIDDM
Number of subjects: 0
Study 9175175 — intervention group
Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to NIDDM (non-CAD) patients
Number of subjects: 0
Study 9175175 — intervention group
Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to severe NIDDM cases
Number of subjects: 0
Study 9175175 — intervention group
Group type: COMPARATOR
Intervention: Fenugreek administration
Number of subjects: 0